Metrics
Publication
56
Open Access
2
UN Sustainable Development Goals
Education
2012 - 2016
2012 - 2016Doctorate
Gazi University, Sağlık Bilimleri Enstitüsü, Farmasotik Kimya (Dr), Turkey
2009 - 2013
2009 - 2013Undergraduate
Anadolu University, Faculty Of Busıness Admınıstratıon, Department Of Busıness, Turkey
2007 - 2012
2007 - 2012Undergraduate
Ankara University, Eczacılık Fakültesi, Eczacılık Pr., Turkey
Dissertations
2016
2016Doctorate
ANTİLÖKOTRİEN ETKİLİ 1,2,5-TRİSÜBSTİTÜE BENZİMİDAZOL TÜREVLERİNİN GELİŞTİRİLMESİ ÜZERİNDE YAPILAN ÇALIŞMALAR
Gazi University, Sağlık Bilimleri Enstitüsü, Farmasotik Kimya (Dr)
Research Areas
Avesis Research Areas:
Pharmacology and Therapeutics, Pharmaceutical Chemistry, Health Sciences
WoS Research Areas:
Chemistry Multidisciplinary, Life Sciences (Life), Chemistry
Scopus Research Areas:
General Chemistry
Research Areas Based on Academic Activities
Avesis Research Areas
WoS Research Areas
Scopus Research Areas
Academic Positions
2023 - Present
2023 - PresentAssociate Professor
Gazi University, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri
2022 - 2023
2022 - 2023Assistant Professor
Gazi University, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri
2016 - 2022
2016 - 2022Research Assistant PhD
Gazi University, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri
2012 - 2016
2012 - 2016Research Assistant
Gazi University, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri
Managerial Experience
2022 - 2024
2022 - 2024Measurement and Evaluation Board Member
Gazi University, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri
Non Academic Experience
2014 - 2014
2014 - 2014Erasmus Öğrenim Hareketliliği
Università degli Studi di Perugia, Erasmus Öğrenim Hareketliliği
Articles
All (22)
SCI-E, SSCI, AHCI (17)
SCI-E, SSCI, AHCI, ESCI (20)
ESCI (3)
Scopus (21)
TRDizin (3)
Other Publications (1)
2026
20261. Encapsulation of the novel mPGES-1 inhibitor TG554 in acetalated dextran nanoparticles
Adermann F., Ismail J., Kohler T., Klepsch L. C., Beringer-Siemers B., Kellner C., et al.
RSC ADVANCES , vol.16, no.29, pp.26869-26879, 2026 (SCI-Expanded, Scopus)
2026
20262. Unveiling the molecular dynamics of a nitrile-containing 5-lipoxygenase-activating protein antagonist in primary macrophages through Raman spectroscopy
Schultz C., Jordan P. M., Dahlke P., GÜR MAZ Z. T., BANOĞLU E., Meyer-Zedler T., et al.
Chemical Science , vol.17, no.3, pp.1613-1623, 2026 (SCI-Expanded, Scopus)
2025
20253. 2-Phenylbenzothiazoles featuring heteroaryl sulfonamide end-capping substructures as developable mPGES-1 inhibitors
Yalcin T., Jordan P. M., OLĞAÇ A., Dahlke P., GÜR MAZ Z. T., BANOĞLU E., et al.
ARCHIV DER PHARMAZIE , vol.358, no.1, 2025 (SCI-Expanded, Scopus)
2024
20244. Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors
Gür Maz T., Dahlke P., Ergül A. G., Olğaç A., Jordan P. M., Çalışkan B., et al.
BIOORGANIC CHEMISTRY
, vol.147, 2024 (SCI-Expanded, Scopus)
2023
20235. Synthesis of some piperazine/piperidine amides of chromone-2-carboxylic acid as potential soluble epoxide hydrolase (sEH) inhibitors
GÜR MAZ Z. T., ÇALIŞKAN H. B.
ORGANIC COMMUNICATIONS , vol.16, 2023 (ESCI, Scopus, TRDizin)
2023
20236. Design, Synthesis and Evaluation of Aryl-Tailored Oxadiazole-thiones as New Urease Inhibitors
Gür Maz Z. T., Caliskan H. B., Capan İ., Caliskan B., Özçelik B., Banoglu E.
CHEMISTRYSELECT
, vol.8, no.8, 2023 (SCI-Expanded, Scopus)
2023
20237. DESIGN AND SYNTHESIS OF SOME ARYLHYDRAZONE DERIVATIVES AS POTENTIAL FAAH INHIBITORS
Gür Maz Z. T., Çalışkan H. B., Turanlı S.
ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI , vol.47, no.1, pp.111-119, 2023 (Scopus, TRDizin)
2023
20238. Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors.
Gür Maz Z. T., Koç B., Jordan P. M., İbiş K., Çalışkan B., Werz O., et al.
ACS OMEGA , vol.8, no.2, pp.2445-2454, 2023 (SCI-Expanded, Scopus)
2022
20229. Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors
Gür Maz Z. T., Turanlı S., Çalışkan H. B., Çalışkan B., Banoğlu E.
ARCHIV DER PHARMAZIE , vol.355, no.8, pp.1-11, 2022 (SCI-Expanded)
2022
202210. A Series of Thiadiazolyl-Benzenesulfonamides Incorporating an Aromatic Tail as Isoform-Selective, Potent Carbonic Anhydrase II/XII Inhibitors
Banoglu E., Ercanlı T., Gür Maz T., Vullo D., Bonardi A., Gratteri P., et al.
CHEMMEDCHEM , vol.17, no.10, 2022 (SCI-Expanded, Scopus)
2022
202211. Novel potent benzimidazole-based microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C4 synthase
Ergül A. G., Maz T. G., Kretzer C., Olğaç A., Jordan P. M., Çalışkan B., et al.
European Journal of Medicinal Chemistry
, vol.231, 2022 (SCI-Expanded, Scopus)
2022
202212. Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201
Kretzer C., Jordan P. M., Bilancia R., Rossi A., Maz T. G., BANOĞLU E., et al.
Journal of Inflammation Research
, vol.15, pp.911-925, 2022 (SCI-Expanded, Scopus)
2021
202113. Simple heteroaryl modifications in the 4,5-diarylisoxazol-3-carboxylic acid scaffold favorably modulates the activity as dual mPGES-1/5-LO inhibitors with in vivo efficacy
Gurses T., OLĞAÇ A., Garscha U., GÜR MAZ Z. T., BAL N. B., Uludag O., et al.
BIOORGANIC CHEMISTRY , vol.112, 2021 (SCI-Expanded, Scopus)
2021
202114. Exploration of anti-tyrosinase effect of Geranium glaberrimum Boiss. & Heldr. with in silico approach and survey of 21 Geranium species
Celikler Ozer O., Erdoğan Orhan İ., Çalışkan B., Senol Deniz F. S., Gokbulut A., Gur Maz T., et al.
JOURNAL OF HERBAL MEDICINE , vol.27, 2021 (SCI-Expanded, Scopus)
2021
202115. Synthesis and evaluation of antibacterial and antimycobacterial activities of some new pyrazole derivatives
Gür Maz Z. T., Karaca N., Levent S., Çalışkan B., Demirci F., Banoğlu E.
JOURNAL OF RESEARCH IN PHARMACY , vol.25, no.5, pp.531-539, 2021 (ESCI, Scopus, TRDizin)
2020
202016. Benzimidazole derivatives as potent and isoform selective tumor-associated carbonic anhydrase IX/XII inhibitors
Uslu A. G., Maz T. G., Nocentini A., BANOĞLU E., Supuran C. T., ÇALIŞKAN B.
BIOORGANIC CHEMISTRY
, vol.95, 2020 (SCI-Expanded, Scopus)
2019
201917. Novel Piperazine Amides of Cinnamic Acid Derivatives as Tyrosinase Inhibitors
GÜR MAZ Z. T., ŞENOL DENİZ F. S., Shekfeh S., ERDOĞAN ORHAN İ., BANOĞLU E., ÇALIŞKAN B.
LETTERS IN DRUG DESIGN & DISCOVERY , vol.16, no.1, pp.36-44, 2019 (SCI-Expanded, Scopus)
2019
201918. Optimisation by design of experiment of benzimidazol-2-one synthesis under flow conditions
Mostarda S., Maz T. G., Piccinno A., Cerra B., Banoğlu E.
Molecules
, vol.24, no.13, 2019 (SCI-Expanded, Scopus)
2018
201819. Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis
Gür Maz Z. T., Çalışkan B., Banoğlu E.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
, vol.153, pp.34-48, 2018 (SCI-Expanded, Scopus)
2018
201820. Crystal structure and Hirshfeld surface analysis of 1-(2,4-dichlorobenzyl)-5-methyl-N-(thiophene-2-sulfonyl)-1H-pyrazole-3-carboxamide
Aydın A., Akkurt M., Gür Maz Z. T., Banoğlu E.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS , vol.74, pp.747-757, 2018 (ESCI, Scopus)
2018
201821. Identification of multi-target inhibitors of leukotriene and prostaglandin E-2 biosynthesis by structural tuning of the FLAP inhibitor BRP-7
GÜR MAZ Z. T., ÇALIŞKAN B., Garscha U., OLĞAÇ A., Schubert U. S., Gerstmeier J., et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
, vol.150, pp.876-899, 2018 (SCI-Expanded, Scopus)
2018
201822. Crystal structure and Hirshfeld surface analysis of methyl 1-(2,4-dichlorobenzyl)-5-methyl-1H-pyrazole-3-carboxylate
Aydın A., Akkurt M., Gür Maz Z. T., Banoğlu E.
European Journal of Chemistry , vol.9, no.4, pp.347-352, 2018 (Peer-Reviewed Journal)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. NOVEL INDOLE-CARBOXAMIDE DERIVATIVES AS HUMAN SOLUBLE EPOXIDE HYDROLASE (sEH) INHIBITORS
Koç B., Gür Maz Z. T., Jordan P. M., Çalışkan K., Çalışkan B., Werz O., et al.
X EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry , Porto, Portugal, 31 August - 04 September 2025, pp.269, (Summary Text)
2023
20232. Evaluation of Indole Based Carboxamide Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors
GÜR MAZ Z. T.
EUROASIA International Congress on Scientific Researches and Recent Trends-X, Baku, Azerbaijan, 16 - 17 February 2023, (Summary Text)
2023
20233. Ibuprofen Based Piperidine Amides as Potential Fatty Acid Amide Hydrolase (FAAH) inhibitors
Gür Maz Z. T., Turanlı S.
The 16th International Scientific Research Congress, Ankara, Turkey, 11 - 12 March 2023, (Summary Text)
2022
20224. A journey from selective FLAP inhibitor to selective mPGES-1 inhibitor: A new therapeutic modality for reducing inflammation and pain
BANOĞLU E., ÇALIŞKAN B., ERGÜL A. G., GÜR MAZ Z. T., OLĞAÇ A., JORDAN P. M., et al.
8th International Bahçeşehir University (BAU) Drug Design Congress, İstanbul, Turkey, 15 - 17 December 2022, (Summary Text)
2022
20225. NOVEL BENZOTHIAZOLE DERIVATIVESAS MICROSOMAL PROSTAGLANDINE E2SYNTHASE-1 (mPGES-1) INHIBITORS
YALÇIN T., GÜR MAZ Z. T., KRETZER C., ÇALIŞKAN B., WERZ O., BANOĞLU E.
9th EFMC Young Medicinal Chemists' Symposium (EFMC-YMCS 2022), Nice, France, 8 - 09 September 2022, (Summary Text)
2022
20226. Novel Microsomal Prostaglandin E2 Synthase-1 (MPGES-1) Inhibitors as a New Modality To Treat Inflammation
ÇALIŞKAN B., ERGÜL A. G., GÜR MAZ Z. T., KRETZER C., OLĞAÇ A., JORDAN P. M., et al.
XXVll EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2022), Nice, France, 4 - 08 September 2022, (Summary Text)
2022
20227. Evaluation of Oxadiazole Derivatives as Promising Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors
GÜR MAZ Z. T., ERGÜL A. G., JORDAN P. M., ÇALIŞKAN B., WERZ O., BANOĞLU E.
XXVll EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2022), Nice, France, 4 - 08 September 2022, (Summary Text)
2022
20228. Benzimidazol türevi öncü bileşiğin in vivo analjezik ve antiinflamatuvar etkilerinin araştırılması
Kaptanoğlu Y., GÜR MAZ Z. T., BAL N. B., BANOĞLU E., ULUDAĞ M. O.
VI. Ulusal Farmasötik Kimya Kongresi, İstanbul, Turkey, 26 - 29 August 2022, pp.199-201, (Summary Text)
2022
20229. Selective or Dual Inhibitors of Inflammatory PGE2 and LTB4 Biosynthesis by Targeting mPGES-1 And FLAP to Intervene with Inflammatory Deregulation
Banoğlu E., Çalışkan B., Ergül A. G., Gür Maz Z. T., Olğaç A., Werz O.
The 6th International Symposium on Pharmaceutical and Biomedical Sciences (ISPBS-6), Gaziantep, Turkey, 26 - 28 May 2022, (Summary Text)
2022
202210. Discovery of Novel Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors: A New Modality to Treat Inflammation
Banoğlu E., Çalışkan B., Ergül A. G., Gür Maz Z. T., Kretzer C., Olğaç A., et al.
10th International Drug Chemistry Conference, Antalya, Turkey, 10 - 13 March 2022, (Summary Text)
2021
202111. Para Kumarik Asidin Heteroarilalkil Amid Türevlerinin Sentezi ve Yağ Asidi Amid Hidrolaz (FAAH) İnhibitör Aktiviteleri
GÜR MAZ Z. T.
33. Ulusal Kimya Kongresi, Turkey, 07 October 2021, (Summary Text)
2021
202112. 2(3H)-BENZOXAZOLONE DERIVATIVES AS POTENTIAL FATTY ACID AMIDE HYDROLASE (FAAH) INHIBITORS
GÜR MAZ Z. T.
3rd International Gazi Pharma Symposium Series, Turkey, 08 September 2021, (Summary Text)
2021
202113. NOVEL PIPERAZINYL UREA DERIVATIVES AS POTENTIAL FATTY ACID AMIDE HYDROLASE (FAAH) INHIBITORS
TURANLI S., ÇALIŞKAN H. B., GÜR MAZ Z. T., ÇALIŞKAN B., BANOĞLU E.
3rd International Gazi Pharma Symposium Series, 08 September 2021, (Summary Text)
2020
202014. Discovery of Multitarget Inhibitors in the Arachidonic Acid Pathway by Targeting FLAP/5-LO/mPGES-1 for Intervention with Inflammatory Deregulation
BANOĞLU E., ÇALIŞKAN B., GÜR MAZ Z. T., OLĞAÇ A., Garscha U., Werz O.
8th International Drug Chemistry Conference, Antalya, Turkey, 27 February - 01 March 2020, (Summary Text)
2018
201815. EVOLUTION OF SELECTIVE FLAP INHIBITOR BRP-7 INTO MULTI-TARGET INHIBITOR OF FLAP, 5-LO AND MPGES-1 IN THE ARACHIDONIC ACID PATHWAY
GÜR MAZ Z. T., ÇALIŞKAN B., OLĞAÇ A., GERSTMEIER J., GARSCHA U., WERZ O., et al.
EFMC International Symposium on Medicinal Chemistry, Ljubljana, Slovenia, 2 - 06 September 2018, pp.231, (Summary Text)
2018
201816. ANTİLÖKOTRİEN ETKİLİ 1,2,5-TRİSÜBSTİTÜEBENZİMİDAZOL TÜREVLERİNİN GELİŞTİRİLMESİ ÜZERİNDE YAPILAN ÇALIŞMALAR
GÜR MAZ Z. T., ÇALIŞKAN B., GERSTMEIER J., OLĞAÇ A., GARSCHA U., WERZ O., et al.
V. ULUSAL FARMASÖTİK KİMYA KONGRESİ, Erzurum, Turkey, 28 April - 01 May 2018, (Summary Text)
2018
201817. Discovery of Tyrosinase Inhibitors from Geranium glaberrimum Boiss. Heldr. Using In Vitro and In Silico Methods
Çelikler Ö., ŞENOL DENİZ F. S., ÇALIŞKAN B., GÜR MAZ Z. T., KAHRAMAN A., ERDOĞAN ORHAN İ., et al.
The 4th Mediterranean Symposium on Medicinal and Aromatic Plants (MESMAP-2018), 18 - 22 April 2018, (Summary Text)
2018
201818. Discovery and Development of Novel Anti-cancer and Anti-inflammatory Compounds: Medicinal Chemistry Challenges
BANOĞLU E., ÇALIŞKAN B., GÜR MAZ Z. T., OLĞAÇ A., İBİŞ K., Akhan Güzelcam E., et al.
The 4th International Symposium on Pharmaceutical and Biomedical Sciences, Kumamoto, Japan, 17 March 2018, (Summary Text)
2017
201719. Developing Multi-target Inhibitors of Arachidonic Acid Pathway Based on the FLAP Inhibitor BRP-7
GÜR Z. T., ÇALIŞKAN B., GERSTMEIER J., OLĞAÇ A., GARSCHA U., WERZ O., et al.
2nd International Gazi Pharma Symposium Series, 11 - 13 October 2017, (Summary Text)
2017
201720. FROM BATCH TO CONTINUOUS FLOW CHEMISTRY:DOE-ASSISTED OPTIMIZATION OF BENZIMIDAZOL-2-ONESYNTHESIS
GÜR Z. T., MOSTARDA S., PICCINNO A., ÇALIŞKAN B., BANOĞLU E., GIOIELLO A.
2nd International Gazi Pharma Symposium Series, 11 - 13 October 2017, (Summary Text)
2017
201721. Tirozinaz İnhibitör Etkili Yeni Sinnamik Asit Türevleri
ÇALIŞKAN B., GÜR Z. T., ŞENOL F. S., SHEKFEH S., ERDOĞAN ORHAN İ., BANOĞLU E.
29. Ulusal Kimya Kongresi, Turkey, 10 - 14 September 2017, pp.452, (Summary Text)
2017
201722. Bioisosteric Tuning of FLAP Inhibitor BRP-7 Towards a More Potent Antiinmlammatory Agent with Multiligand Inhibitor Properties in the Arachidonic Acid (AA) Pathway
GÜR Z. T., ÇALIŞKAN B., OLĞAÇ A., GERSTMEIER J., GARSCHA U., WERZ O., et al.
EFMC-ASMC’xx17 EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry, 27 - 31 August 2017, (Summary Text)
2017
201723. Araşidonik asit yolağında çoklu ligand (FLAP/5-LO/mPGES-1) özellikte inhibitör etkili BRP-7 türevlerinin geliştirilmesi
BANOĞLU E., GÜR Z. T., ÇALIŞKAN B., GERSTMEIER J., OLĞAÇ A., GARSCHA U., et al.
1. Anadolu Üniversitesi Eczacılık Sempozyumu, Eskişehir, Turkey, 1 - 02 June 2017, pp.10, (Summary Text)
2016
201624. Novel BRP 7 Derivatives Targeting FLAP Potent Inhibitors of Leukotriene Biosynthesis
GÜR Z. T., ÇALIŞKAN B., GERSTMEIER J., GARSCHA U., OLĞAÇ A., WERZ O., et al.
3rd EFMC Young Medicinal Chemist Symposium, Manchester, United Kingdom, 1 - 02 September 2016, (Summary Text)
2016
201625. EXPLORATION OF THE CHEMICAL SPACE AROUND C 5 POSITION OF THE BENZIMIDAZOLE NUCLEUS IN BRP 7 TOWARDS MORE POTENT INHIBITORS OF HUMAN 5 LIPOXYGENASE ACTIVATING PROTEIN FLAP
GÜR Z. T., ÇALIŞKAN B., Gerstmeier J., OLĞAÇ A., nikels F., werz o., et al.
EFMC International Symposium on Medicinal Chemistry, Manchester, United Kingdom, 28 August - 01 September 2016, (Summary Text)
2015
201526. STRUCTURE BASED DESIGN AND SYNTHESIS OF NOVEL BRP 7 DERIVATIVES BEARING C 5 POLAR SUSBTITUENTS AS POTENT FLAP INHIBITORS
GÜR Z. T., OLĞAÇ A., Gerstmeiner J., Macchiarulo A., Werz O., ÇALIŞKAN B., et al.
GPSS 2015, Antalya, Turkey, 12 - 15 November 2015
2014
201427. Structure-Based Design and Synthesis of Novel BRP-7 Derivatives as Potent FLAP Inhibitors: Insights from MolecularDynamics Simulations.
OLĞAÇ A., GÜR Z. T., CAROTTI A., ÇALIŞKAN B., GERSTMEIER J., WERZ O., et al.
EFMC International Symposium on Medicinal Chemistry, LİZBON, Portugal, 7 - 11 September 2014, pp.162, (Summary Text)
Books
2025
20251. Lokal Anestezikler
GÜR MAZ Z. T., ERGÜL A. G.
in: Farmasötik Kimya Akıl Notları, ŞİMŞEK RAHİME, Editor, Güneş Tıp Kitabevleri, pp.425-434, 2025
2025
20252. Genel Anestezikler
GÜR MAZ Z. T., ÇALIŞKAN B.
in: Farmasötik Kimya Akıl Notları, ŞİMŞEK RAHİME, Editor, Güneş Tıp Kitabevleri, pp.121-131, 2025
Funded Projects
2025 - Present
2025 - PresentÇözünür Epoksit Hidrolaz (sEH) İnhibitörlerinin Paklitaksel ile İndüklenen Nöropatik Ağrı Modelinde Etkinliğinin Araştırılması
Project Supported by Higher Education Institutions , BAP Research Project
BAL N. B. (Executive), BANOĞLU E., ÇALIŞKAN B., BELEN H. B., BAHÇELİOĞLU M., GÜR MAZ Z. T., et al.
2025 - 2028
2025 - 2028Yeni Çözünür Epoksit Hidrolaz (Seh) İnhibitörlerinin Geliştirilmesi Ve In Vivo Etkinliklerinin Değerlendirilmesi Üzerine Çalışmalar
TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects
Çalışkan B. (Executive), Bal N. B., Banoğlu E., Werz O., Çalışkan K., Gür Maz Z. T.
2024 - 2026
2024 - 2026Bazı Yeni İndol Türevi Çözünür Epoksit Hidrolaz İnhibitörlerinin Geliştirilmesi Üzerine Çalışmalar
Project Supported by Higher Education Institutions , BAP Research Project
GÜR MAZ Z. T. (Executive), BANOĞLU E., KOÇ B., ÇALIŞKAN B., İBİŞ K., WERZ O., et al.
2019 - 2023
2019 - 2023
Yeni Mikrozomal Prostaglandin E2 Sentaz-1 (Mpges-1) İnhibitörlerinin Geliştirilmesi Üzerine Çalışmalar
TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects
(Project Abstract)
Banoğlu E. (Executive), Gür Maz Z. T., Uludağ M. O., Çalışkan B., Olğaç A., Bal N. B.
2020 - 2022
2020 - 2022Yeni Piperazinilüre Türevlerinin sentezi ve FAAH İnhibitörü Aktivitelerinin İncelenmesi
Project Supported by Higher Education Institutions , BAP Research Project
GÜR MAZ Z. T. (Executive), BANOĞLU E., ÇALIŞKAN B., TURANLİ S.
2020 - 2022
2020 - 2022Yeni Tiyadiazol Türevlerinin sentezi ve Karbonik Anhidraz İnhibitörü Aktivitelerinin Karakterizasyonu
Project Supported by Higher Education Institutions , BAP Research Project
BANOĞLU E. (Executive), GÜR MAZ Z. T., ERCANLI T.
2017 - 2019
2017 - 2019Pirazol-5-karboksilik asit sülfonamit türevlerinin sentezi ve antimikrobiyal aktivitelerinin değerlendirilmesi
Project Supported by Higher Education Institutions , BAP Research Project
Gür Maz Z. T. (Executive), Çalışkan B., Banoğlu E., Demirci F.
2013 - 2016
2013 - 2016
5 Lipoksijenaz aktive edici protein FLAP inhibitörlerinin geliştirilmesi
TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects
(Project Abstract)
Banoğlu E. (Executive), Çalışkan B.
Patent
2026
2026Benzimidazol Bileşikleri Ve Bunları İçeren Farmasötik Bileşimler Ve Kullanımları
Patent
Pending / Applied, The Invention Recourse Number: 2026/002346 , Standard Registration
2023
2023BENZIMIDAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
Patent
Pending / Applied, The Invention Recourse Number: PCT/TR2023/050887 , Standard Registration
2022
2022BENZİMİDAZOL TÜREVİ MİKROZOMAL PROSTAGLANDİN E2 SENTAZ-1 (mPGES-1) İNHİBİTÖRLERİ
Patent
Pending / Applied, The Invention Recourse Number: 2022/011123 , Standard Registration
Memberships and Roles in Scientific Organizations
2012 - Present
2012 - PresentTürk Farmasötik ve Medisinal Kimya Derneği
Member
Mobility Activity
2014 - 2014
2014 - 2014Erasmus Programme
Student Mobility
Universita Degli Studi di Perugia, Italy
Congress and Symposium Activities
04 September 2022 - 08 September 2022
04 September 2022 - 08 September 2022